title: Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.
authors.forename: L
authors.initials: L
authors.lastname: Mosca
authors.forename: J E
authors.initials: JE
authors.lastname: Manson
authors.forename: S E
authors.initials: SE
authors.lastname: Sutherland
authors.forename: R D
authors.initials: RD
authors.lastname: Langer
authors.forename: T
authors.initials: T
authors.lastname: Manolio
authors.forename: E
authors.initials: E
authors.lastname: Barrett-Connor
mesh_terms: D000572:American Heart Association; D001157:Arterial Occlusive Diseases / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D003276:Contraceptives, Oral; D003327:Coronary Disease / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D005006:Ethnicity; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D017698:Postmenopause; D011322:Primary Prevention; D012307:Risk Factors; D012737:Sex Factors; D014481:United States / Q000453:epidemiology; D016387:Women's Health
chemical_list: D003276:Contraceptives, Oral